期刊文献+

乳腺癌患者血清CA15-3的临床意义 被引量:3

CLINICAL SIGNIFICANCE OF DETERMINATION OF SERUM CA 15-3 IN PATIENTS WITH BREAST CARCINOMA
下载PDF
导出
摘要 用IRMA法检测42例乳腺癌患者术前和术后第2周血清CA15-3值,并结合临床病理资料进行分析。结果,血清CA15-3水平与淋巴结转移状态显著相关(P<0.01);术前术后CA15-3水平差异有显著性(P<0.05);其中3例有远处转移的病人,其CA15-3值均高于100u/ml。因而认为,血清CA15-3水平可作为乳腺癌转移的辅助性诊断手段,并用于估计肿瘤转移的潜在可能性。 An immunoradiomeric assay (IRMA) has been used to determine circulating levels of CA 15-3 of 42 patients with breast cancer.The results indicated that the levels of CA 15-3 show a significant correlation with status of lymphatic matastases, that preoperative levels of CA 15-3 differ significantly from postoperative levels of CA 15-3 (P<0.01),and that 3 patients with distant matastases all have levels of CA 15-3 more than 100 u/ml.So it is considered that CA 15-3 might be a useful indicator in monitoring the clinical course of patients with breast cancer and be used as an adjunctive measure for diagnosis of metastatic breast cancer.
出处 《南通医学院学报》 1996年第3期333-334,共2页 ACTA Academiae Medicinae Nantong
关键词 乳腺癌 癌抗原15-3 肿瘤 标记 血清 breast cancer CA 15-3 tumor marker
  • 相关文献

同被引文献21

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部